Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nyse  >  Aetna Inc    AET

Delayed Quote. Delayed  - 07/29 10:01:28 pm
115.21 USD   -0.50%
07/29 When Big Insurance Companies Merge, Who Benefits?
07/29DJCigna Misses, Cuts Guidance
07/29 AETNA : Earnings schedule for the week of 8/1/2016
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 

Aetna Profit Declines As Health-Care Costs Rebound

share with twitter share with LinkedIn share with facebook
share via e-mail
0
04/26/2012 | 10:53pm CEST

--Aetna earnings decline, missing analyst expectations

--Insurer didn't benefit from surplus money set aside to pay claims, as it did a year ago

--Company reiterates full-year guidance

(Adds company comments regarding expected cost trends and reserve assumptions. Adds closing stock price.)

 
   By Jon Kamp 
   Of  
 

Aetna Inc.'s (>> Aetna Inc.) first-quarter earnings declined 13%, falling short of Wall Street expectations, after the insurer found it didn't have a surplus in money set aside to cover earlier patient claims, a possible indication patients are making more doctors visits after a long slump.

Aetna and other insurers establish reserves to cover claims for the current period and prior ones. If those reserves wind up too high, as has been the trend with patients lightly using health-care services, the extra money is added to earnings.

In the first quarter, the money Aetna set aside for fourth-quarter claims turned out to be more on target, leaving less money to add to the bottom line. Aetna pegged the lack of extra money to stabilizing medical costs late last year, but was hesitant to suggest usage trends are significantly changing.

Everybody is "sort of feeling for the bottom here where a trend stops decelerating and starts to tick up," said Mark Bertolini, Aetna's chairman and chief executive, on a call with analysts.

The company on Thursday maintained its forecast for an uptick in health-system usage this year. A spokeswoman said Aetna is comfortable with its reserve assumptions for the first quarter based on its expectation for rising costs. Chief Financial Officer Joseph Zubretsky said on the call that Aetna has made "prudent assumptions regarding medical cost trends for 2012."

Still, the disappointing results spooked investors, who sent Aetna shares plunging, down 8.2% to $45.31. The news also weighed on some other insurers, as UnitedHealth Group Inc. (UNH) slipped 0.9% to $58.37, and Cigna Inc. (>> CIGNA Corporation) declined 1.4% to $47.56.

There could be broader implications, as Goldman Sachs analyst Matthew Borsch said the pressure on margins seen at Aetna "reflects industry trends more than company-specific issues." This pressure comes from a mix of modestly increasing medical cost trends and intensifying price competition, the analyst said.

Health-care observers have been watching for an acceleration in medical usage after a long period of patients avoiding visits to doctors' offices and hospitals because of the still-uncertain economy. Recent signals from around the health-care sector have been mixed, with signs of higher spending coming from some corners, such as among replacement-joint manufacturers.

CFO Zubretsky said Aetna's results reflect "the stabilizing medical cost trend we observed in the fourth quarter." He noted that earlier last year, trends that reflect a mix of health costs and how much patients use the system decreased significantly below Aetna's expectations, leading to positive reserves.

In an interview, Zubretsky added that the company isn't saying this cost trend picked up in the fourth quarter. Rather, "I would say it stopped decelerating," he said.

Aetna said its total medical-benefit ratio--or the amount of premiums used to pay patient medical costs--rose to 81.5% in the first quarter, from 79.2% a year earlier and 80.7% in the prior quarter.

The ratio was pushed lower last year by the fact Aetna set aside more money than it wound up needing to pay claims. "There was no significant prior-years reserve development in the first quarter of 2012," Aetna said Thursday.

Overall, Aetna reported a first-quarter profit of $511 million, or $1.43 a share, down from $586 million, or $1.50 a share, a year earlier. Operating earnings in the latest period were $1.34 a share.

Revenue excluding capital gains and losses increased 6.2% to $8.86 billion, mostly owing to higher health-care premiums and fees. Analysts polled by Thomson Reuters had projected earnings of $1.40 a share on revenue of $8.69 billion.

After the strong results from other insurers, "and the market's optimistic assumptions about where Aetna's guidance could go, it's hard to see how this quarter isn't viewed as a disappointment," Citigroup analyst Carl McDonald said.

Despite the light first-quarter earnings, the company reiterated its guidance for full-year operating earnings of about $5 a share, while saying it expects to boost membership over the year after a first-quarter decline.

Aetna ended the first quarter with about 17.9 million medical members, a decline of 544,000 from the fourth quarter, reflecting an expected decrease in the company's commercial business and the company's exit from Connecticut's Medicaid program. Bertolini said Aetna expects to grow to 18.2 million medical members over the course of this year.

"We're seeing positive momentum in our 2013 selling season with early National Accounts wins and new business opportunities that are twice what they were a year ago," the CEO said.

-By Jon Kamp, Dow Jones Newswires; 617-654-6728; jon.kamp@dowjones.com

Order free Annual Report for Aetna, Inc.

Visit http://djnweurope.ar.wilink.com/?ticker=US00817Y1082 or call +44 (0)208 391 6028

Order free Annual Report for CIGNA Corp.

Visit http://djnweurope.ar.wilink.com/?ticker=US1255091092 or call +44 (0)208 391 6028

Order free Annual Report for UnitedHealth Group, Inc.

Visit http://djnweurope.ar.wilink.com/?ticker=US91324P1021 or call +44 (0)208 391 6028

Stocks mentioned in the article : Aetna Inc., CIGNA Corporation
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on AETNA INC
07/29 When Big Insurance Companies Merge, Who Benefits?
07/29DJCigna Misses, Cuts Guidance
07/29 AETNA : Earnings schedule for the week of 8/1/2016
07/28AETNA INC : half-yearly earnings release
07/27 AETNA : Boys Arnold & Co INC Decreased Stake in Aetna INC New by $6.85 Million a..
07/26 AETNA : Georgia officials postpone Aetna-Humana merger hearing
07/25DJCanceled Deals Put M&A Record at Risk -- WSJ
07/25 AETNA : NOAA deploys another smart buoy in the bay
07/24 AETNA : Cigna Futures Foggy In Wake Of Justice Department Decisions To Block Dea..
07/22 AETNA INC /PA/ : Other Events, Financial Statements and Exhibits (form 8-K)
More news
Sector news : Managed Healthcare - NEC
07/29DJCIGNA : Misses, Cuts Guidance -- Update
07/29DJCigna Misses, Cuts Guidance
07/29DJCIGNA : Misses, Cuts Guidance
07/28DJANTHEM : Turns Less Bullish On Exchanges -- WSJ
07/27DJAlere Faces Criminal Probe Over Medicare, Medicaid Billing
More sector news : Managed Healthcare - NEC
News from SeekingAlpha
07/21 U.S. Gov sues to block two health insurance mega-mergers
07/21 WALL STREET BREAKFAST : ECB Holds First Meeting Since Brexit
07/21 Aetna, Humana still talking to DOJ
07/20 United Health Today, Centene And Humana Tomorrow
07/19 U.S. to oppose Cigna/Humana deals
Advertisement
Financials ($)
Sales 2016 63 076 M
EBIT 2016 4 540 M
Net income 2016 2 638 M
Debt 2016 4 521 M
Yield 2016 0,87%
P/E ratio 2016 15,48
P/E ratio 2017 13,88
EV / Sales 2016 0,71x
EV / Sales 2017 0,66x
Capitalization 40 393 M
More Financials
Chart AETNA INC
Duration : Period :
Aetna Inc Technical Analysis Chart | AET | US00817Y1082 | 4-Traders
Full-screen chart
Technical analysis trends AETNA INC
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 23
Average target price 138 $
Spread / Average Target 20%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Mark T. Bertolini Chairman & Chief Executive Officer
Karen S. Lynch President
Margaret M. McCarthy Executive Vice President-Operations & Technology
Shawn M. Guertin CFO, Executive VP & Chief Enterprise Risk Officer
Harold L. Paz Chief Medical Officer & Executive Vice President
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
AETNA INC6.56%40 393
UNITEDHEALTH GROUP INC21.73%136 155
ANTHEM INC-5.81%34 565
CIGNA CORPORATION-11.87%33 080
HUMANA INC-3.34%25 716
CENTENE CORP7.20%12 045
More Results